Position in MIRM
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$45,727,544
+$20,388,897 QoQ
Shares Held
494,994
+54.3% QoQ
Ownership
0.812%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 97.5908798894532.ToString("F0")%
Shared 0.ToString("F0")%
None 2.4091201105467945.ToString("F0")%
Common Shares in MIRM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS Group AG holds $8,307,109,707 across 562 Biotechnology names. MIRM ranks #44 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
22,619,472 | $626,559,372 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
5,177,796 | $545,739,697 | |
| 3 | ABVX |
Abivax S.A.
|
4,547,406 | $506,353,656 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
4,386,791 | $426,615,424 | |
| 5 | INSM |
INSMED Inc
|
1,737,481 | $284,112,890 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
630,618 | $281,596,158 | |
| 7 | APLS |
Apellis Pharmaceuticals, Inc.
|
6,206,681 | $249,694,775 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
299,979 | $231,775,770 |
All Filings in MIRM
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $45,727,544 | 494,994 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $25,338,647 | 320,783 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $20,221,976 | 275,842 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $9,285,184 | 182,456 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $10,629,861 | 235,957 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $7,632,754 | 184,589 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $4,851,210 | 124,390 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,734,902 | 50,743 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $3,941,603 | 156,911 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $3,499,330 | 118,541 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $6,098 | 193 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $2,862,410 | 110,646 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $974,394 | 40,566 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $2,088,761 | 107,116 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $377,696 | 17,977 | Shares | Sole | 2022-11-10 | |
| 2021-12-31 | $39,571 | 2,481 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $15,019 | 754 | Shares | Defined | 2021-11-15 | |
| 2021-03-31 | $23,011 | 1,161 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $254,112 | 14,554 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $276,505 | 14,349 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $307,409 | 15,797 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $238,000 | 17,000 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||